<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05097092</url>
  </required_header>
  <id_info>
    <org_study_id>2021-101</org_study_id>
    <nct_id>NCT05097092</nct_id>
  </id_info>
  <brief_title>Strength Training Augmenting Rehabilitation</brief_title>
  <acronym>STAR</acronym>
  <official_title>Strength Training Augmenting Rehabilitation - 1</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Texas Christian University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Texas Christian University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This project aims to determine whether a novel strength training rehabilitation protocol can&#xD;
      diminish the negative consequences of limb immobilization and expedite the restoration of&#xD;
      muscle function during retraining in healthy individuals.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The present study will examine the time course of muscle strength and size adaptations in two&#xD;
      groups of volunteers during immobilization and retraining. Both groups will undergo temporary&#xD;
      muscle disuse by wearing a shoulder sling and swathe on their non-dominant arm for ~≥10&#xD;
      hours/day for four weeks. One group (immobilization + unilateral training) will perform&#xD;
      progressive unilateral strength training of the free limb throughout the immobilization&#xD;
      period. The other group (immobilization control) will not undergo any training during the&#xD;
      immobilization period. Following immobilization, both groups will undergo four weeks of&#xD;
      bilateral strength training to retrain the immobilized arm.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 13, 2021</start_date>
  <completion_date type="Anticipated">August 14, 2023</completion_date>
  <primary_completion_date type="Anticipated">August 13, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in isometric muscle strength</measure>
    <time_frame>Changes from baseline at 5 and 10 weeks</time_frame>
    <description>MVC (Newton)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes in dynamic muscle strength</measure>
    <time_frame>Changes from baseline at 5 and 10 weeks</time_frame>
    <description>1RM (lbs)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes in muscle size</measure>
    <time_frame>Changes from baseline at 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 weeks</time_frame>
    <description>Ultrasound muscle thickness of biceps brachii and triceps brachii</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes in lean mass</measure>
    <time_frame>Changes from baseline at 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 weeks</time_frame>
    <description>DEXA</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes in EMG amplitude</measure>
    <time_frame>Changes from baseline at 5 and 10 weeks</time_frame>
    <description>Surface EMG</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes in action potential amplitude</measure>
    <time_frame>Changes from baseline at 5 and 10 weeks</time_frame>
    <description>Surface EMG Decomposition</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Muscle Disuse Atrophy</condition>
  <arm_group>
    <arm_group_label>Immobilization control</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The immobilization control group will undergo arm immobilization. Immobilization will be implemented with four weeks of muscle unloading with a sling and swathe on the nondominant arm. The sling will suspend the arm at the elbow joint with the elbow in a flexed position at 90°, the swathe will then wrap around the participant to fix the arm against the body.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Immobilization with unilateral training</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The immobilization with unilateral training group will undergo arm immobilization for four with a sling and swathe on the nondominant arm. The sling will suspend the arm at the elbow joint with the elbow in a flexed position at 90°, the swathe will then wrap around the participant to fix the arm against the body. The free (non-immobilzed) arm of this group will undergo heavy strength training twice per week throughout the immobilization period. The training will consist of unilateral dumbbell shoulder press and biceps curl.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Orthopedic immobilization</intervention_name>
    <description>Orthopedic immobilization will be performed with a sling and swathe.</description>
    <arm_group_label>Immobilization control</arm_group_label>
    <arm_group_label>Immobilization with unilateral training</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Unilateral resistance training</intervention_name>
    <description>Unilateral resistance training will be performed by the dominant arm of the immobilization + unilateral resistance training group during Phase 1.</description>
    <arm_group_label>Immobilization with unilateral training</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Bilateral resistance training</intervention_name>
    <description>Bilateral resistance training will be performed by both arms in both groups during Phase 2.</description>
    <arm_group_label>Immobilization control</arm_group_label>
    <arm_group_label>Immobilization with unilateral training</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  a body mass index between 18 - 35 kg/m2&#xD;
&#xD;
          -  18-35 years of age&#xD;
&#xD;
          -  right-hand dominant&#xD;
&#xD;
          -  willingness to comply with the immobilization requirements&#xD;
&#xD;
          -  willingness to refrain from strength training outside of the study&#xD;
&#xD;
          -  willingness to comply with the strength training procedures of the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  a personal or family history of blood clots&#xD;
&#xD;
          -  a personal or family history of thyroid disorders&#xD;
&#xD;
          -  previous orthopedic surgeries to the upper limbs and/or joint pain of the upper limbs&#xD;
             in the last 6 months&#xD;
&#xD;
          -  neuromuscular or metabolic disorders&#xD;
&#xD;
          -  osteoarthritis&#xD;
&#xD;
          -  use of hormone replacement therapy (ie., testosterone, estrogen, and/or growth hormone&#xD;
             pharmaceuticals)&#xD;
&#xD;
          -  pregnancy and/or nursing&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>TCU Neuromuscular Physiology Laboratory</name>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <zip>76126</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Enrolling by invitation</status>
  </location>
  <location>
    <facility>
      <name>TCU RIC</name>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <zip>76126</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joshua C Carr</last_name>
      <phone>917-257-6867</phone>
      <email>joshua.carr@tcu.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>September 22, 2021</study_first_submitted>
  <study_first_submitted_qc>October 14, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 27, 2021</study_first_posted>
  <last_update_submitted>October 14, 2021</last_update_submitted>
  <last_update_submitted_qc>October 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Texas Christian University</investigator_affiliation>
    <investigator_full_name>Joshua Carr</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Muscular Disorders, Atrophic</mesh_term>
    <mesh_term>Atrophy</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

